Major Interests in Shares

RNS Number : 2961Q
Alliance Pharma PLC
30 July 2010
 



For immediate release

30 July 2010

 

Alliance Pharma plc

 

TR-1: Notification of major interests in shares

 

 

1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:
ii

Alliance Pharma plc  

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

Yes

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached


An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments


An event changing the breakdown of voting rights


Other (please specify):

On market transfer between indirect and direct funds

Yes

3. Full name of person(s) subject to the
notification obligation:
iii

Aviva plc & its subsidiaries    

4. Full name of shareholder(s)
 (if different from 3.):iv

Registered Holder:

 

BNY Norwich Union Nominees Limited           1,494,754*                                                              

 

Chase (GA Group) Nominees Limited              9,622,074*

 

CUIM Nominee Limited                                   2,356,377*

                                                             

*denotes direct interest

 

BNP Paribas - London                                    1,846,572

 

Chase Nominees Limited                                6,144,127

 

State Street Nominees Limited                        2,352,851

 

5. Date of the transaction and date on
which the threshold is crossed or
reached:
v

29 July 2010

6. Date on which issuer notified:

30 July 2010

7. Threshold(s) that is/are crossed or
reached:
vi, vii

4% to 5% Change at Direct Interest Level

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ordinary Shares


GB0031030819

23,316,755

23,316,755

23,816,755

13,473,205

10,343,550

5.79%

4.45%



B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date
xiii

Exercise/
Conversion Period
xiv

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights







 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date xvii

Exercise/
Conversion period
xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 





 

 

Nominal

Delta



Total (A+B+C)

Number of voting rights

Percentage of voting rights

23,816,755

10.24%

 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
xxi

The voting rights are managed and controlled by Aviva Investors Global Services Limited, with the following chain of controlled undertakings:-

 

Aviva Investors Global Services Limited:

·      Aviva plc (Parent Company)

·      Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc)

·      Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group Holdings Limited)

·      Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva Investors Holdings Limited)

 

 

 


Proxy Voting:

10. Name of the proxy holder:

See Section 4

11. Number of voting rights proxy holder will cease
to hold:


12. Date on which proxy holder will cease to hold
voting rights:




13. Additional information:


Figures are based on the total number of voting rights of  232,533,372.

14. Contact name:

     Diane Thirkettle

15. Contact telephone number:

     01603 687803

 

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLLLFIEDTIIVII
UK 100

Latest directors dealings